Journals / Cukurova Medical Journal / 2021 / Cilt: 46 - Sayı: 4

Pleomorfic xanthoastrocytoma with dural involvement

Dural tutulumu olan pleomorfik ksantoastrositom

Pages
1727–1729
Publication Date
2021-12-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Pleomorphic xanthoastrocytomas (PXAs) are rare neoplasms comprising less than 1% of all astrocytic tumors, are World Health Organization (WHO) grade II glial tumour.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Pleomorphic xanthoastrocytomas (PXAs) are rare neoplasms comprising less than 1% of all astrocytic tumors, are World Health Organization (WHO) grade II glial tumour.
📊
Key Findings & Data:Pleomorphic xanthoastrocytomas (PXAs) are rare neoplasms comprising less than 1% of all astrocytic tumors, are World Health Organization (WHO) grade II glial tumour.
💡
Conclusion & Impact:Pleomorphic xanthoastrocytomas (PXAs) are rare neoplasms comprising less than 1% of all astrocytic tumors, are World Health Organization (WHO) grade II glial tumour.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Pleomorfik ksantoastrositom · Nöbet · Çocukluk çağı

Abstract

Pleomorphic xanthoastrocytomas (PXAs) are rare neoplasms comprising less than 1% of all astrocytic tumors, are World Health Organization (WHO) grade II glial tumour.

Özet

Pleomorfik ksantoastrositomlar (PXA), Dünya Sağlık Örgütü (WHO) derece II glial tümör olup tüm astrositik tümörlerin %1'inden azını oluşturan nadir görülen neoplazilerdir.

🔖

Cite This Article

AKŞAN, İ. O., AKOĞLU, H. A. (2021). Pleomorfic xanthoastrocytoma with dural involvement. Cukurova Medical Journal, Cilt: 46 - Sayı: 4, 1727–1729. https://ajindex.com/articles/420766

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Giannini C, Scheithauer BW, Burger PC, Brat DJ, Wollan PC, Lach B. Pleomorphic xanthoastrocytoma: what do we really know about it? Cancer. 1999;85:2033– 45 2. Kepes JJ, Rubinstein LJ, Eng LF. Pleomorphic xanthoastrocytoma: a distinctive meningocerebral glioma of young subjects with relatively favorable prognosis. A study of 12 cases. Cancer. 1979;44:1839– 52. 3. Oh T, Kaur G, Madden M, Bloch O, Parsa AT. Pleomorphic xanthoastrocytomas: institutional experience of 18 patients. J Clin Neurosci. 2014;21:1767–72. 4. Ida CM, Rodriguez FJ, Burger PC, Caron AA, Jenkins SM, Spears GM et al. Pleomorphic xanthoastrocytoma: natural history and long-term follow-up. Brain Pathol. 2015; 5:575-86. 5. Perkins SM, Mitra N, Fei W, Shinohara ET. Patterns of care and outcomes of patients with pleomorphic xanthoastrocytoma: a SEER analysis. J Neurooncol 2012;S110:99–104 6. Rumboldt Z, Castillo M, Huang B, Rossi A. Brain Imaging with MRI and CT. New York, Cambridge University Press, 2012. 7. Crespo-Rodríguez AM, Smirniotopoulos JG, Rushing EJ. MR and CT imaging of pleomorphic xanthoastrocytomas (PXA) and a review of the literature. Neuroradiology. 2007; 49:307-15. 8. Yu S, He L, Zhuang X, Luo B. Pleomorphic xanthoastrocytoma: MR imaging findings in 19 patients. Acta Radiol. 2011; 52:223-8. 9. Moore W, Mathis D, Gargan L, Bowers D.C, Klesse L.J, Margraf L et al. Pleomorphic xanthoastrocytoma of childhood: MR imaging and diffusion MR imaging features. AJNR Am J Neuroradiol. 2014; 35:2192–96. 10. Rao AA, Laack NN, Giannini C, Wetmore C. Pleomorphic xanthoastrocytoma in children and adolescents. Pediatr Blood Cancer. 2010; 55:290-4.